| Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 E Treiner, L Duban, S Bahram, M Radosavljevic, V Wanner, F Tilloy, ... Nature 422 (6928), 164-169, 2003 | 1179 | 2003 |
| Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17–secreting T cells M Dusseaux, E Martin, N Serriari, I Péguillet, V Premel, D Louis, M Milder, ... Blood, The Journal of the American Society of Hematology 117 (4), 1250-1259, 2011 | 1041 | 2011 |
| A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules NC Fernandez, E Treiner, RE Vance, AM Jamieson, S Lemieux, ... Blood 105 (11), 4416-4423, 2005 | 730 | 2005 |
| An invariant T cell receptor α chain defines a novel TAP-independent major histocompatibility complex class Ib–restricted α/β T cell subpopulation in mammals F Tilloy, E Treiner, SH Park, C Garcia, F Lemonnier, H De La Salle, ... The Journal of experimental medicine 189 (12), 1907-1921, 1999 | 658 | 1999 |
| Stepwise development of MAIT cells in mouse and human E Martin, E Treiner, L Duban, L Guerri, H Laude, C Toly, V Premel, ... PLoS biology 7 (3), e1000054, 2009 | 650 | 2009 |
| MAIT cells detect and efficiently lyse bacterially-infected epithelial cells L Le Bourhis, M Dusseaux, A Bohineust, S Bessoles, E Martin, V Premel, ... PLoS pathogens 9 (10), e1003681, 2013 | 413 | 2013 |
| Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases NE Serriari, M Eoche, L Lamotte, J Lion, M Fumery, P Marcelo, ... Clinical & Experimental Immunology 176 (2), 266-274, 2014 | 354 | 2014 |
| NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model NT Joncker, NC Fernandez, E Treiner, E Vivier, DH Raulet The Journal of Immunology 182 (8), 4572-4580, 2009 | 341 | 2009 |
| CD1d-and MR1-restricted invariant T cells: of mice and men E Treiner, O Lantz Current opinion in immunology 18 (5), 519-526, 2006 | 152 | 2006 |
| Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset E Treiner, L Duban, IC Moura, T Hansen, S Gilfillan, O Lantz Microbes and infection 7 (3), 552-559, 2005 | 136 | 2005 |
| Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients L Zabijak, C Attencourt, C Guignant, D Chatelain, P Marcelo, ... Cancer immunology, immunotherapy 64, 1601-1608, 2015 | 119 | 2015 |
| Treatment of progressive multifocal leukoencephalopathy with nivolumab O Walter, E Treiner, F Bonneville, C Mengelle, F Vergez, F Lerebours, ... New England Journal of Medicine 380 (17), 1674-1676, 2019 | 88 | 2019 |
| Mucosal-associated invariant T cells in chronic inflammatory liver disease FJ Bolte, B Rehermann Seminars in liver disease 38 (01), 060-065, 2018 | 38 | 2018 |
| Mucosal-associated invariant T cells in multiple sclerosis: the jury is still out E Treiner, RS Liblau Frontiers in immunology 6, 503, 2015 | 32 | 2015 |
| Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors X Boumaza, B Bonneau, D Roos‐Weil, C Pinnetti, S Rauer, L Nitsch, ... Annals of neurology 93 (2), 257-270, 2023 | 29 | 2023 |
| Mucosal-associated invariant T cells in inflammatory bowel diseases: bystanders, defenders, or offenders? E Treiner Frontiers in immunology 6, 27, 2015 | 24 | 2015 |
| MR1B, a natural spliced isoform of the MHC‐related 1 protein, is expressed as homodimers at the cell surface and activates MAIT cells J Lion, V Debuysscher, A Wlodarczyk, A Hodroge, NE Serriari, L Choteau, ... European journal of immunology 43 (5), 1363-1373, 2013 | 22 | 2013 |
| Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response Y Renaudineau, F Abravanel, J Izopet, C Bost, E Treiner, N Congy, ... Clinical Immunology 237, 108979, 2022 | 18 | 2022 |
| Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progression G Dorcet, H Migné, D Biotti, C Bost, F Lerebours, J Ciron, E Treiner Journal of Neurology 269 (10), 5443-5453, 2022 | 13 | 2022 |
| MAIT cells display a specific response to type 1 IFN underlying the adjuvant effect of TLR7/8 ligands M Pavlovic, C Gross, C Chili, T Secher, E Treiner Frontiers in Immunology 11, 2097, 2020 | 13 | 2020 |
